Implementation Facilitation Pilot for Alcohol Use Disorder (AUD) in Alcohol-associated Liver Disease (ALD)

Recruiting now · Not applicable

Conditions studied: Alcohol Use Disorder, Alcohol-associated Liver Disease

In brief

The goal of this project is to improve provision of integrated medications for alcohol use disorder (MAUD) with brief counseling for patients with alcohol use disorder (AUD) and alcohol-associated liver disease (ALD) in hepatology clinics. There are many benefits of AUD treatment among patients with AUD and ALD such as reduction in liver-related complications and hepatology clinicians providing this care in an integrated fashion can improve access and uptake.

Key facts

Study ID

NCT07525258

Run by

Yale University

People needed

30

Starts

2026-04-05

Expected to finish

2029-04-01

Last updated by the study team

2026-05-07

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Must provide care for patients with liver disease at a hepatology clinical location within the Yale School of Medicine and YNHH medical system.

You may not qualify if…

• Providers who do not treat patients with chronic liver disease and alcohol-associated liver disease.

Where it is running

• Yale School of Medicine/Yale-New Haven Health — New Haven, Connecticut, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.